These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 26737239)

  • 21. Arterial stiffness and medial temporal lobe atrophy in elders with memory disorders.
    Lilamand M; Vidal JS; Plichart M; De Jong LW; Duron E; Hanon O
    J Hypertens; 2016 Jul; 34(7):1331-7. PubMed ID: 27136311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early diagnosis of Alzheimer's disease: contribution of structural neuroimaging.
    Chetelat G; Baron JC
    Neuroimage; 2003 Feb; 18(2):525-41. PubMed ID: 12595205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Italian Alzheimer's Disease Neuroimaging Initiative (I-ADNI): validation of structural MR imaging.
    Cavedo E; Redolfi A; Angeloni F; Babiloni C; Lizio R; Chiapparini L; Bruzzone MG; Aquino D; Sabatini U; Alesiani M; Cherubini A; Salvatore E; Soricelli A; Vernieri F; Scrascia F; Sinforiani E; Chiarati P; Bastianello S; Montella P; Corbo D; Tedeschi G; Marino S; Baglieri A; De Salvo S; Carducci F; Quattrocchi CC; Cobelli M; Frisoni GB
    J Alzheimers Dis; 2014; 40(4):941-52. PubMed ID: 24577455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HYDRA: Revealing heterogeneity of imaging and genetic patterns through a multiple max-margin discriminative analysis framework.
    Varol E; Sotiras A; Davatzikos C;
    Neuroimage; 2017 Jan; 145(Pt B):346-364. PubMed ID: 26923371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of medial and lateral temporal lobe atrophy in dementia with Lewy bodies and Alzheimer's disease: magnetic resonance imaging volumetric study.
    Barber R; McKeith IG; Ballard C; Gholkar A; O'Brien JT
    Dement Geriatr Cogn Disord; 2001; 12(3):198-205. PubMed ID: 11244213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [MRI of medial-temporal atrophy as a biomarker for Alzheimer's disease].
    Elsiddig AAI; Grosu C; Ferrer Soler C; Scheffler M; Cotta Ramusino M; Trombella S; Gold G; Boccardi M; Frisoni GB
    Rev Med Suisse; 2018 Sep; 14(620):1716-1720. PubMed ID: 30255999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical validity of medial temporal atrophy as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework.
    Ten Kate M; Barkhof F; Boccardi M; Visser PJ; Jack CR; Lovblad KO; Frisoni GB; Scheltens P;
    Neurobiol Aging; 2017 Apr; 52():167-182.e1. PubMed ID: 28317647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased cortical glucose metabolism correlates with hippocampal atrophy in Alzheimer's disease as shown by MRI and PET.
    Yamaguchi S; Meguro K; Itoh M; Hayasaka C; Shimada M; Yamazaki H; Yamadori A
    J Neurol Neurosurg Psychiatry; 1997 Jun; 62(6):596-600. PubMed ID: 9219745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increasing the diagnostic accuracy of medial temporal lobe atrophy in Alzheimer's disease.
    Jacobs HI; Van Boxtel MP; van der Elst W; Burgmans S; Smeets F; Gronenschild EH; Verhey FR; Uylings HB; Jolles J
    J Alzheimers Dis; 2011; 25(3):477-90. PubMed ID: 21471642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential diagnosis of mild cognitive impairment and Alzheimer's disease using structural MRI cortical thickness, hippocampal shape, hippocampal texture, and volumetry.
    Sørensen L; Igel C; Pai A; Balas I; Anker C; Lillholm M; Nielsen M;
    Neuroimage Clin; 2017; 13():470-482. PubMed ID: 28119818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation between hippocampal volumes and medial temporal lobe atrophy in patients with Alzheimer's disease.
    Dhikav V; Duraiswamy S; Anand KS
    Ann Indian Acad Neurol; 2017; 20(1):29-35. PubMed ID: 28298839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New MRI markers for Alzheimer's disease: a meta-analysis of diffusion tensor imaging and a comparison with medial temporal lobe measurements.
    Clerx L; Visser PJ; Verhey F; Aalten P
    J Alzheimers Dis; 2012; 29(2):405-29. PubMed ID: 22330833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. White matter hyperintensities on MRI in dementia with Lewy bodies, Parkinson's disease with dementia, and Alzheimer's disease.
    Joki H; Higashiyama Y; Nakae Y; Kugimoto C; Doi H; Kimura K; Kishida H; Ueda N; Nakano T; Takahashi T; Koyano S; Takeuchi H; Tanaka F
    J Neurol Sci; 2018 Feb; 385():99-104. PubMed ID: 29406924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Automatic temporal lobe atrophy assessment in prodromal AD: Data from the DESCRIPA study.
    Chincarini A; Bosco P; Gemme G; Esposito M; Rei L; Squarcia S; Bellotti R; Minthon L; Frisoni G; Scheltens P; Frölich L; Soininen H; Visser PJ; Nobili F;
    Alzheimers Dement; 2014 Jul; 10(4):456-467. PubMed ID: 24035058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Longitudinal Neuroimaging Hippocampal Markers for Diagnosing Alzheimer's Disease.
    Platero C; Lin L; Tobar MC
    Neuroinformatics; 2019 Jan; 17(1):43-61. PubMed ID: 29785624
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Temporal lobe atrophy on magnetic resonance imaging in the diagnosis of early Alzheimer's disease.
    Erkinjuntti T; Lee DH; Gao F; Steenhuis R; Eliasziw M; Fry R; Merskey H; Hachinski VC
    Arch Neurol; 1993 Mar; 50(3):305-10. PubMed ID: 8442711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and APO E4 medial temporal lobe dementias. The Oxford Project to Investigate Memory and Aging.
    Jobst KA; Barnetson LP; Shepstone BJ
    Int Psychogeriatr; 1997; 9 Suppl 1():191-222; discussion 247-52. PubMed ID: 9447442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relation between medial temporal atrophy and functional brain activity during memory processing in Alzheimer's disease: a combined MRI and SPECT study.
    Garrido GE; Furuie SS; Buchpiguel CA; Bottino CM; Almeida OP; Cid CG; Camargo CH; Castro CC; Glabus MF; Busatto GF
    J Neurol Neurosurg Psychiatry; 2002 Nov; 73(5):508-16. PubMed ID: 12397142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates.
    Scheltens P; Leys D; Barkhof F; Huglo D; Weinstein HC; Vermersch P; Kuiper M; Steinling M; Wolters EC; Valk J
    J Neurol Neurosurg Psychiatry; 1992 Oct; 55(10):967-72. PubMed ID: 1431963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of automated volumetry of the hippocampus using NeuroQuant® and visual assessment of the medial temporal lobe in Alzheimer's disease.
    Persson K; Barca ML; Cavallin L; Brækhus A; Knapskog AB; Selbæk G; Engedal K
    Acta Radiol; 2018 Aug; 59(8):997-1001. PubMed ID: 29172642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.